Difference between revisions of "Bavituximab (PGN-401)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Warner-admin moved page Bavituximab (PGN401) to Bavituximab (PGN-401) without leaving a redirect) |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
=Preliminary data= | =Preliminary data= | ||
==[[Non-small cell lung cancer]]== | ==[[Non-small cell lung cancer]]== | ||
| − | # Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS, Gerber DE. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. Epub 2014 Aug 24. [http://www.lungcancerjournal.info/article/S0169-5002(14)00355-9 | + | # Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS, Gerber DE. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. Epub 2014 Aug 24. [http://www.lungcancerjournal.info/article/S0169-5002(14)00355-9 link to original article] [https://pubmed.ncbi.nlm.nih.gov/25236982/ PubMed] |
| + | |||
| + | ==Also known as== | ||
| + | *'''Code name:''' PGN-401 | ||
| + | *'''Brand name:''' Tarvacin | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| − | |||
| − | |||
[[Category:Anti-PS antibodies]] | [[Category:Anti-PS antibodies]] | ||
| − | [[Category:Non-small cell lung cancer medications]] | + | [[Category:Non-small cell lung cancer medications (investigational)]] |
| − | [[Category:Investigational]] | + | [[Category:Investigational drugs]] |
Latest revision as of 00:22, 29 July 2023
Mechanism of action
Binds to phosphatidylserine, provoking an immune response.
Preliminary data
Non-small cell lung cancer
- Digumarti R, Bapsy PP, Suresh AV, Bhattacharyya GS, Dasappa L, Shan JS, Gerber DE. Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer. Lung Cancer. 2014 Nov;86(2):231-6. Epub 2014 Aug 24. link to original article PubMed
Also known as
- Code name: PGN-401
- Brand name: Tarvacin